´ëÇѼîÅ©¿¬±¸È¸ Çмú´ëȸ : 2023-12-12
±³À°ÀÏÀÚ : 2023-12-12
±³À°Àå¼Ò : ¼¿ï¾Æ»êº´¿ø ¿¬±¸¿ø ÁöÇÏ1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ : ´ëÇѼîÅ©¿¬±¸È¸ Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÀÀ±ÞÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѼîÅ©¿¬±¸È¸
´ã´çÀÚ : À¯½Â¸ñ
¿¬¶ôó : 010-2932-3342
À̸ÞÀÏ : shockkr@bjsolution.kr
±³À°Á¾·ù : ³»°ú, Áø´Ü°Ë»çÀÇÇаú, ÀÀ±ÞÀÇÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 25ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í Àü¹®ÀÇ(40,000¿ø), Àü°øÀÇ/±âŸ(30,000¿ø)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 10:05~10:25 Biomarkers for sepsis: Presepsin ¼ÛÁÖÇö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 10:25~10:45 Biomarkers for AKI: NGAL ±è¼ÖÀÙ(AMCÁø´Ü°Ë»çÀÇÇаú)
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 10:45~11:05 Biomarkers for shock: Renin ÀÌ°ÇŹ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 11:05~11:25 Biomarkers for coagulation: TEG ¿°¼®¶õ(ºÎ»êÀÇ´ë)
Åä·Ð 12¿ù 12ÀÏ ´ë°´ç 11:25~11:35 Discussion ()
ÈÞ½Ä 12¿ù 12ÀÏ 11:35~11:50 Coffee break ()
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 11:50~12:15 Early infection control in septic shock ÀåÀÇÁø(AMC°¨¿°³»°ú)
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 12:15~12:40 Massive transfusion protocol in trauma ÀÌÇÐÀç(AMCÀϹݿܰú)
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 12:40~13:05 Steroid application strategy in sepsis ¾ÈÁöȯ(AMCÈ£Èí±â³»°ú)
Åä·Ð 12¿ù 12ÀÏ ´ë°´ç 13:05~13:15 Discussion ()
½Ä»ç 12¿ù 12ÀÏ 13:15~14:30 Lunch break ()
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 15:00~15:20 Novel patient monitoring device ÃÖ¿íÁø(¿ï»êÀÇ´ë)
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 15:20~15:40 Machine learning & Ai ±ÇÁظí(Medical Ai ´ëÇ¥)
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 15:40~16:00 From hemodynamic to cell ±è±Ô¼®(Â÷ÀÇ°ú´ëÇÐ)
Åä·Ð 12¿ù 12ÀÏ ´ë°´ç 16:00~16:10 Discussion ()
ÈÞ½Ä 12¿ù 12ÀÏ 16:10~16:25 Coffee break ()
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 16:25~16:55 Current status sepsis management in Korea: KSA À̼ö¿¬(AMCÈ£Èí±â³»°ú)
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 16:55~17:20 Review of recent clinical trials in sepsis ¾ÈÄ¡¿ø(Áß¾Ó´ëÀÇ´ë)
±³À°½Ã°£ 12¿ù 12ÀÏ ´ë°´ç 17:20~17:45 Review of recent basic researches in sepsis ¹ÚÀοø(¼¿ïÀÇ´ë)